IGC Pharma
IGC
#10700
Rank
A$36.58 M
Marketcap
A$0.35
Share price
1.02%
Change (1 day)
-44.92%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Market capitalization of IGC Pharma (IGC)

Market cap: A$36.58 Million

As of October 2026 IGC Pharma has a market cap of A$36.58 Million. This makes IGC Pharma the world's 10700th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of IGC Pharma from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026A$36.58 M-12.01%
2025A$41.58 M-9.75%
2024A$46.07 M75.83%
2023A$26.2 M5.63%
2022A$24.8 M-63.93%
2021A$68.76 M-20.78%
2020A$86.8 M143.77%
2019A$35.6 M126.3%
2018A$15.73 M-56.27%
2017A$35.97 M226.38%
2016A$11.02 M95.45%
2015A$5.64 M-49.28%
2014A$11.11 M19.49%
2013A$9.3 M19.26%
2012A$7.8 M32.07%
2011A$5.9 M-39.1%
2010A$9.7 M-51.04%
2009A$19.81 M42.82%
2008A$13.87 M-85.29%
2007A$94.3 M-8.91%
2006A$0.10 B

End of Day market cap according to different sources

On Oct 25th, 2026 the market cap of IGC Pharma was reported to be:

A$36.22 Million
by Nasdaq info icon info icon
A$36.22 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sterling Infrastructure
STRL
A$15.81 B 43,110.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
A$2.90 B 7,835.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
A$6.88 B 18,724.98%๐Ÿ‡บ๐Ÿ‡ธ USA